Live News EQUITY FLASH L impact Oct 30, 2026, 12:53 PM UTC Oppenheimer Raises Ligand Pharmaceuticals Price Target to $346 From $334 Oppenheimer kept its Outperform rating on Ligand Pharmaceuticals. LGND SquawkNews Desk